DOCSLIB.ORG

SABIN VACCINE REPORT the Newsletter of the Albert B

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SABIN VACCINE REPORT the Newsletter of the Albert B SABIN VACCINE REPORT the newsletter of the Albert B. Sabin Vaccine Institute at Georgetown University Volume I, Number 1, September 1998 IN THIS ISSUE Institute Announces Sabin Vaccine Institute Announces Sabin-Hilleman Fellows Program Sabin and Hilleman are the inspiration for program aimed at promoting Sabin-Hilleman Fellows Program vaccinology and immunology. BY ERICA SEIGUER By participating in existing internships, or in projects 1 In keeping with one of its central missions, the Albert designed through a collaboration between the stu- B. Sabin Vaccine Institute has recently created the Sabin- dent and mentor, the Sabin-Hilleman Fellows will Neal Nathanson: New OAR Head Brings Diplomacy, Toughness Hilleman Fellows Program. A tribute to the pioneering work be exposed to the latest in vaccine design and imple- Renowned for his work on polio of two great figures in vaccinology, Albert B. Sabin and Maurice mentation. Possible projects might include intern- epidemiology, Nathanson filled the vacancy left by Bill Paul in November 1997. R. Hilleman, the Fellows Program will nurture talented high ships at the Global Programme for Vaccines and Im- 1 school students and undergraduates as they pursue their in- munization at the World Health Organization or in Op/Ed terests in the health sciences, particularly in vaccinology and a research laboratory at the National Institutes of Vaccines as an Instrument of immunology. Sabin Vaccine Institute Chairman H.R. Shep- Health. International Diplomacy 2 herd, a close friend of both Hilleman and the late Sabin, un- The Institute will begin the selection pro- derscores that the program is designed to encourage the next cess in February 1999, when application materials A Model of Government-Industry Collaboration, Avirons Intranasal generation of scientists and health professionals to dedicate are due. The first Sabin-Hilleman Fellows will be no- Flu Vaccine Paves the Way for themselves to health promotion through disease prevention. tified in April of their acceptance and the internships Needleless Protection The world’s first intranasal vaccine “The Fellows Program will provide young people with an ex- will begin shortly thereafter. Mrs. Heloisa Sabin, co- protected 93% of children against traordinary opportunity to gain unique insight into the worlds founder of the Institute, is looking forward to meet- flu in a 1997 NIH clinical trial. 3 of immunology and vaccinology. The Institute is committed ing the Sabin-Hilleman Fellows: “Albert used to say to training the next generation of leaders in the health sci- to young people with ideas and interest in vaccinology Institute Awards Gala Honors Vernon Loucks, ences.” that during his thirty years in the development of Nicholas Zwick and Myron Levine The program, developed by Herbert Herscowitz, the oral polio vaccine, for every gratification, he had Annual benefit gala draws on Institute supporters from industry, academia, Georgetown University Professor of Microbiology and Immu- at least 100 frustrations. He told them not to give government, as well as legends in jazz. nology, the Academy for Educational Development, and Sabin up. The Fellows Program will be important in ensur- 4 Institute staff, will support Sabin-Hilleman Fellows’ participa- ing that they do not give up.” v Asias Other Crisis tion in activities aimed at the prevention of disease through Yale University and Sabin Institute Neal Nathanson: New OAR Head scientist Peter Hotez is working on a the better use of vaccines. They will meet policy-makers, vac- vaccine for parasitic worms. Brings Diplomacy, Toughness 6 BY PATRICIA THOMAS Sabin Calendar “History will judge us according to Translational Research, whether we develop a vaccine for AIDS,” Neal Cancer Symposium and more... Nathanson said, speaking from the periphery 6 of a crowded meeting room at the National In- stitutes of Health. The need for a preventive vac- Sabin Institute Bookshelf cine is urgent, he continued, and the NIH must Science for the 21st Century: preserve the clinical trials system that has been The Bush Report Revisited testing candidate vaccines for the past 10 7 years. Only two weeks into his job as the new Sabin Institute in the News director of the Office of AIDS Research (OAR) at NIH, Nathanson had come to the June 2 8 photo courtesy of L. Rosenthal Sabin-Hilleman Fellows will gather to discuss key issues in vaccine meeting of the AIDS Research Advisory Com- development and implementation. mittee expecting to listen, not talk. But that A scientist who is also a human being resolve melted by mid-afternoon, after officials cannot rest while knowledge which might cine scientists, and clinicians from academia and industry at from the Division of AIDS (DAIDS) had laid out be used to reduce suffering sits on the shelf. Institute conferences. Following their work experience, fellows their plans for changing how the NIH tests HIV vaccines and other preventive measures. Far Albert B. Sabin will stay in touch with each other and the Institute through an from rubber-stamping the DAIDS plan, mem- alumni network. It is hoped that the relationships forged will bers of this top-level advisory committee chipped away at its administrative details, es- The Albert B. Sabin Vaccine Institute is facilitate the continuous sharing of knowledge and ideas, with pecially provisions that might impinge on their a non-profit institute dedicated to the ultimate goal of accelerating the development of new vac- own roles in clinical trials. Finally the discus- continuing the work and achieving the sion bogged down in the pros and cons of al- vision of Albert B. Sabin: to fully realize cines, methods to deliver them, and immunization strategies. lowing institutions that had not already done the enormous potential of vaccination to The Program is focused on high school students and HIV vaccine trials to compete for places in the prevent disease. new network. That brought Nathanson to his undergraduates, who are eligible to participate in internships feet. and research experiences that enhance the three-fold mission “I had the feeling that there were people Founded in 1994, the Institute strives obsessing about the process and forgetting to prevent death by promoting the of the Sabin Vaccine Institute: about the product,” he said later. “I’m not inter- development of new vaccines and ¨ stimulating progress in vaccine science; ested in open competition, I’m interested in a delivery systems. product. What the world needs is not an open ¨ advocating sound policy for the development and use competition – it needs a vaccine.” With 35 years of vaccines; of experience in virology, epidemiology, and pub- lic health, including leadership positions at two Dedicated to Disease Prevention ¨ educating the public about vaccines and immuniza- top medical schools, Nathanson has long had tion. continued on page 6 www.sabin.georgetown.edu SABIN VACCINE REPORT September 1998 Vaccines as Peace Makers THE ALBERT B. SABIN VACCINE INSTITUTE How vaccines could alter the face of conflict in Asia AT GEORGETOWN UNIVERSITY by Peter J. Hotez and H.R. Shepherd CHAIRMAN H.R. Shepherd The shadow that AIDS casts over our planet portends incomprehensible tragedy, and the shadow is growing darker. The new United Nations Report on the Global AIDS Epidemic documents a deadly disease spreading across our EXECUTIVE VICE PRESIDENT Edward Niese MD PhD planet like an eclipse. Last year, 2.3 million people died of AIDS. Thirty million people are infected with HIV, the virus that causes AIDS; 10 million have become infected in just the last two years. In Botswana and Zimbabwe, one in four VICE PRESIDENT adults are infected. In several other African countries, the infection rate is one in five. Peter J. Hotez MD PhD Although the report has focused attention on Africa, a newer and possibly more frightening HIV epidemic has BOARD OF DIRECTORS started to roll through densely populated areas of the Indian subcontinent and China. India already has more HIV- Jason S. Berman infected people — four million — than any other country. The number of HIV-infected people in China is believed to Zev Braun Kenneth L. Dretchen PhD have doubled since 1996. Conditions in Pakistan are ripe for an outbreak there. Robert E. Fuisz MD Over the last two years, new combination drug therapies have helped control the spread of HIV in developed E. Andrews Grinstead III Jerome Jacobson countries, such as the United States. But these therapies cost $10,000 or more per patient per year. Even with recently David J. Meiselman Esq announced discounts for developing countries where HIV is spreading most rapidly, these drugs remain utterly unaffordable Lewis A. Miller Louis Padovano SJ MD to more than 90% of the world’s HIV-infected population. Moreover, new studies indicate that patients taking the Maj. Gen. Philip K. Russell MD combination therapies can still transmit HIV, and some suffer side effects that may create serious new health problems. Heloisa Sabin Carol Ruth Shepherd The only sure way to halt the AIDS epidemic is with a vaccine. Although scientists have been trying to develop H.R. Shepherd a vaccine for over a decade and a potential vaccine just entered a large, Phase III trial, the research effort must be BOARD OF TRUSTEES intensified. More than five million people become infected each year that passes without a vaccine. Ruth Arnon PhD An AIDS vaccine has the potential to do more than conquer this deadly disease. The quest to develop a vaccine Nancy Gardner Hargrave Joseph L. Melnick PhD can resolve conflict in volatile regions such as South Asia. It can draw together scientists, advocates, and government Gustav J.V. Nossal MD PhD health officials from countries recently engaged in nuclear saber rattling, such as India, Pakistan, and China, and unite George C. St. Laurent Jr Kathryn G. Thompson them in a common cause. A joint AIDS vaccine development effort can help defuse a potential powder keg.
Load more

Recommended publications
  • TESTIMONY Peter J. Hotez MD, Phd President, Sabin Vaccine Institute
    TESTIMONY Peter J. Hotez MD, PhD President, Sabin Vaccine Institute “The Growing Threat of Cholera and Other Diseases in the Middle East” Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations Committee on Foreign Affairs United States House of Representatives March 2, 2016 Mr. Chairman and Members of the Subcommittee, thank you for the opportunity to speak with you today. I am Peter Hotez, a biomedical scientist and pediatrician. I am the dean of the National School of Tropical Medicine at Baylor College of Medicine and also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics based at the Texas Medical Center in Houston. I am also past president of the American Society of Tropical Medicine and Hygiene, and currently serve as President of the Sabin Vaccine Institute, a non-profit which develops vaccines for neglected tropical diseases (NTDs) through a product development partnership (PDP) model. This year I am also serving as US Science Envoy for the State Department and White House Office of Science and Technology Policy focusing on the urgency to develop vaccines for diseases that are emerging in the Middle East and North Africa due to the breakdowns in health systems in the ISIS occupied conflict zones in Syria, Iraq, Libya, and also Yemen. In my submitted written testimony I highlighted some of the successes in US global health policy, many of which can be attributed to the hard work of this Subcommittee working hand in glove with two presidential administrations since 2000. I cite evidence from the Global Burden of Disease Study (GBD) that brings together hundreds of scientists - I am also a part of this - who are measuring the impact of large scale global health programs.
    [Show full text]
  • Sabin in the News Recent Scientific Articles Sabin Vaccine Institute
    Home About Us News & Resources Support Sabin Sabin in the News October 2011 The Sabin Report | Volume 13 Issue 2 New York Times article featuring Dr. Peter Hotez's new study on increased Sabin Vaccine Institute Establishes a Houston prevalence of NTDs in Europe. Office Drs. Ciro de Quadros and In September 2011, the Zulfiqar Bhutta highlight Sabin Vaccine Institute the dire need for a dengue established offices in vaccine in an opinion Houston, Texas in the piece for GlobalPost. heart of the city's Texas Medical Center (TMC). The In an interview on Voice of new facilities will house the America Dr. Peter Hotez Sabin Vaccine Institute & focused on NTDs in Sub- Texas Children's Hospital Saharan Africa. Center for Vaccine Development, which will be An article by Dr. Neeraj operated in partnership Mistry was featured in a with Baylor College of special supplemental Medicine Department of section of the USA today, Pediatrics. Sabin Dr. Hotez and team at Sabin's new Houston facility titled "Neglected Diseases President, Dr. Peter J. in Developing Nations". Hotez will direct the new center. In an op-ed for the Houston Chronicle, Dr. The new space includes offices and laboratories through which the Peter Hotez writes about Sabin Vaccine Institute Product Development Partnership (PDP) will the establishment of the advance and strengthen its collaborative work in the field of vaccine new School of Tropical biotechnology. The change is the result of a year-long plan to expand Medicine at Baylor College the scope and depth of the Sabin PDP's partnership and to enhance of Medicine.
    [Show full text]
  • 2004 Albert B. Sabin Gold Medal Address Delivered by Award Recipient William S
    2004 Albert B. Sabin Gold Medal Address Delivered by Award Recipient William S. Jordan, Jr., M.D. With a Tribute by John R. LaMontagne, Ph.D. May 25, 2004 Arlington, Virginia INTRODUCTION by H.R. Shepherd, D.Sc. Chairman, The Albert B. Sabin Vaccine Institute he Sabin Vaccine Institute pursues Dr. Albert B. Sabin’s vision of a T world protected from disease by vaccines. The annual awarding of the Sabin Gold Medal has always been among our most meaningful traditions. The 2004 award was presented in May to an icon in vaccine research, William S. Jordan, Jr., M.D., at a ceremony in Arlington, Virginia, during the 7th Annual Conference on Vaccine Research, co-organized by the Sabin Vaccine Institute. The positive impact of vaccines on the health and well being of humanity continues to be a marvel of our modern world. Vaccine improvements, new vaccines, and vaccines in the pipeline represent an advancing field of science that brings untold preventive benefit to millions around the world. Along with his career in vaccine research, Dr. Jordan has engaged in compiling the record of scientific advancements in the field. His name is synonymous with both vaccine research and the compendium—The Jordan Report—that for 25 years has been a repository for advances in the vaccine field. The Sabin Gold Medal Advisory Committee, chaired by Maj. Gen. Philip K. Russell, M.D. (USA Ret.), selected Dr. Jordan for this honor after canvassing 300 members of the scientific community. We are pleased to recognize Dr. Jordan with this honor, noting his exemplary contributions in the vaccine field and commitment to lifesaving medical discoveries.
    [Show full text]
  • Poliomyelitis in the Lone Star State
    POLIOMYELITIS IN THE LONE STAR STATE: A BRIEF EXAMINATION IN RURAL AND URBAN COMMUNITIES THESIS Presented to the Graduate Council of Texas State University in Partial Fulfillment of the Requirements For the Degree Master of Arts By Jason C. Lee San Marcos, Texas December, 2005 Insert signature page here ii COPYRIGHT By Jason Chu Lee 2005 iii ACKNOWLEDGEMENTS It leaves me in a stupor to contemplate all those I have to thank for aiding me in this effort. If I leave anybody out, please accept my most humble apologies, as the list is long. I will be the first to admit that this work is flawed, despite the best efforts of my committee to save me from myself. Had I utilized them more, this piece would only be improved. I had never undertaken a project of this scope before and though I believe I have accomplished much, the experience has been humbling. Never again will I utter the phrase, “just a thesis.” My biggest thanks go out to Dr. Mary Brennan, my committee chair and mentor. Without her guidance I most certainly would have needed to take comprehensive finals to graduate. She helped me salvage weeks of research that I thought had no discernable use. But Dr. Brennan, despite her very, very busy schedule with the department and her family, still found the time to help me find my thesis in all the data. She is well loved in the department for obvious reasons, as she has a gift for being firm and professional while remaining compassionate. Dr. James Wilson and Dr.
    [Show full text]
  • Dr Sabin's Legacy to the World Jaime Sepulveda
    World Health • 46th Year, No . 3, Moy-June 1993 IS Dr Sabin's legacy to the world Jaime Sepulveda oliomyelitis has been eradicated Poliomyelitis acquired epidemic from the Americas and other proportions in the Americas at the end Pareas, and is expected to be of the last century, mainly in the most eliminated from the world by 1995. developed regions. In Mexico, the first This outstanding achievement has epidemic outbreaks started in the been made possible thanks to the 1940s and caused many victims. The availability of an excellent vaccine oral poliovaccine was made available coupled with successful vaccination in Mexico in the early 1960s. programmes. Few actions in public Coverage was low then, and mainly health have become so deservedly concentrated among well-to-do prestigious as the vaccination children. In the 1970s, a new national campatgns. programme reached much greater The first major achievement of the numbers of children and poliomyelitis immunization effort was the cases began to drop. eradication from the world of However, it was not until1985 that smallpox in the late 1970s. But the a new polio immunization initiative success with smallpox is only the took place, with the goal of reaching all children, regardless of social status Or Albert Bruce Sobin, who perfected the first most visible component of all the viable live vaccine against polio. many benefits conferred by or geographic location. This new immunization programmes strategy, focusing on "National worldwide. Not only have they Vaccination Days", was originally brought about the survival of children proposed by Professor Albert Sabin, who would otherwise have died; they the US scientist who developed the have greatly enhanced the quality of oral poliomyelitis vaccine.
    [Show full text]
  • Robert Purcell: Okay
    Office of NIH History Oral History Interview with Dr. Robert H. Purcell (NIAID, LID) Conducted on December 7, 2005, by Dr. Lisa K. Walker At the National Institutes of Health, Bethesda, Maryland Abstract: Dr. Purcell describes his education and training, his early career in the Laboratory of Infectious Diseases, and his work since he has headed LID studies of hepatitis viruses. He describes how the LID broadened its work, from a focus on viruses causing respiratory diseases through the early 1960s, to include hepatitis as well as gastroenteritis viruses. He also discusses internal collaborations at NIH and extramural collaborations, and many of the chance findings and coincidences that helped to further study of hepatitis and control of infection. Dr. Purcell also comments on how advances in technology and instrumentation have influenced the study of hepatitis viruses. Lisa Walker: I would like to start out by hearing a little bit about your growing up, and your family and your decisions as you entered university and training in chemistry to begin with. Robert Purcell: Okay. I was born in Iowa and moved to Texas when I was six months old, and spent my first nine years in Dallas, Texas. Then my family moved to rural Oklahoma, and that’s where I lived until I finished college and then went off to medical school. I guess I developed an interest in science from my brother, who was in college and was taking science courses, [and] who would come home with interesting little tidbits about things, and that really kind of excited me. The school I went to, since it was in rural Oklahoma, actually was a minimal school.
    [Show full text]
  • COLLEGE of LETTERS and SCIENCE ALUMNI: KNOWLEDGE in ACTION COLLEGE of LETTERS and SCIENCE Dear Friends and Colleagues, Dean, Nicol C
    THE COLLEGE OF LETTERS AND SCIENCE • MONTANA STATE UNIVERSITY • 2016-2017 • VOLUME 13 COLLEGE OF LETTERS AND SCIENCE ALUMNI: KNOWLEDGE IN ACTION COLLEGE OF LETTERS AND SCIENCE Dear friends and colleagues, Dean, Nicol C. Rae Associate Dean, David Cherry In 2016, Montana State University Associate Dean, Bridget Kevane celebrated and honored the legacy of Director of Finance and Administration, Mindy Brown Assistant to the Dean, Sarah Miller Maurice Hilleman, the College of Letters Administrative and Student Support Coordinator, and Science’s—and arguably MSU’s— Nicol Rae. Jennifer Storment most world-changing alumnus. Communications Director, Jody Sanford Advising Coordinator, Erica Dungan Hillman graduated from MSU in 1941 with degrees in chemistry and Accounting Operations Manager, Cassandra Balent microbiology. He pursued a career as a microbiologist, specializing in vaccinology Information Technology Director, Michael Wright and developing over 40 vaccines, an unparalleled record of productivity. Of the COLLEGE OF LETTERS AND SCIENCE 14 vaccines routinely recommended in current vaccine schedules, he developed ADVISORY COUNCIL eight: those for measles, mumps, hepatitis A, hepatitis B, chickenpox, meningitis, Michael Beehler Betsy Quammen pneumonia and Haemophilus influenzae bacteria. He also played a role in the Julianne Bye Peter Roos discovery of the cold-producing adenoviruses, the hepatitis viruses and the cancer- Ingrid Degreef Peter Sadowski Marshall Gingery Bradley Snow causing virus SV40. He is credited with saving more lives than any other medical Ariana Paliobagis Gary Stoner scientist of the 20th century. Gary Popiel William Yellowtail Jr. In April of this year, MSU held the Maurice Hilleman Vaccine Symposium, DEPARTMENTS AND DEPARTMENT HEADS featuring some of the nation’s most noted experts in vaccine.
    [Show full text]
  • Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA
    GENE SILENCING BY DOUBLE STRANDED RNA Nobel Lecture, December 8, 2006 by Andrew Z. Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA. I would like to thank the Nobel Assembly of the Karolinska Institutet for the opportunity to describe some recent work on RNA-triggered gene silencing. First a few disclaimers, however. Telling the full story of gene silencing would be a mammoth enterprise that would take me many years to write and would take you well into the night to read. So we’ll need to abbreviate the story more than a little. Second (and as you will see) we are only in the dawn of our knowledge; so consider the following to be primer... the best we could do as of December 8th, 2006. And third, please understand that the story that I am telling represents the work of several generations of biologists, chemists, and many shades in between. I’m pleased and proud that work from my labo- ratory has contributed to the field, and that this has led to my being chosen as one of the messengers to relay the story in this forum. At the same time, I hope that there will be no confusion of equating our modest contributions with those of the much grander RNAi enterprise. DOUBLE STRANDED RNA AS A BIOLOGICAL ALARM SIGNAL These disclaimers in hand, the story can now start with a biography of the first main character. Double stranded RNA is probably as old (or almost as old) as life on earth.
    [Show full text]
  • Renato Dulbecco
    BIOLOGIE ET HISTOIRE Renato Dulbecco Renato Dulbecco : de la virologie à la cancérologie F.N.R. RENAUD 1 résumé Né en Italie, Renato Dulbecco fait de brillantes études médicales mais est plus intéressé par la recherche en biologie que par la pratique médicale. Accueilli par Giuseppe Levi, il apprend l’histologie et la culture cellulaire avant de rejoindre le laboratoire de S.E. Luria puis celui de M. Delbrück pour travailler sur les systèmes bactéries-bactériophages puis sur la relation cellules-virus. Il met au point la méthode des plages de lyse virales sur des cultures cellulaires. Il est aussi à l’origine de la virologie tumorale moléculaire. D. Baltimore, HM Temin et lui-même sont récompensés par le prix Nobel de médecine et physiologie en 1975 pour leurs travaux sur l'interaction entre les virus tumoraux et le matériel génétique du matériel cellulaire. Très tourné vers les aspects pratiques et expérimentaux de la recherche, il est resté le plus long - temps possible à la paillasse et a initié un très grand nombre de jeunes chercheurs. mots-clés : culture cellulaire, virologie tumorale, plages de lyse, bactériophages. I. - LA JEUNESSE DE RENATO DULBECCO C'est à Catanzaro, capitale régionale de la Calabre en Italie, que naît Renato Dulbecco le 22 février 1914. Sa mère est Calabraise et son père Ligurien. Il ne reste que très peu de temps dans le sud de l’Italie, car son père est mobilisé et sa famille doit déménager dans le nord à Cuneo, puis à Turin. À la fin de la guerre, la famille Dulbeco s'ins - talle à Imperia en Ligurie.
    [Show full text]
  • The March of Dimes and Polio: Lessons in Vaccine Advocacy for Health Educators
    Feature Article The March of Dimes and Polio: Lessons in Vaccine Advocacy for Health Educators Dawn Larsen ABSTRACT The polio vaccine became available in 1955, due almost entirely to the efforts of the March of Dimes. In 1921, Franklin Roosevelt gave a public face to polio and mounted a campaign to prevent it, establishing the National Foundation for Infantile Paralysis in 1938. During the Depression, U.S. citizens were asked to contribute one dime. Entertainer Eddie Cantor suggested the name the March of Dimes, paraphrasing the popular newsreel “The March of Time.” Jonas Salk advocated a killed-virus vaccine while Albert Sabin proposed a live-virus vaccine. Both competed for both recognition and funding from the March of Dimes. In 1955 Salk’s vaccine was adopted, nationwide vaccination programs were implemented, and polio rates dropped by 80 percent. In 1961, Sabin’s vaccine, endorsed by the American Medical Association, became the vaccine of choice. The World Health Assembly advocated polio eradication by the year 2000. By 2004 eradication efforts were threatened by allegations linking vaccines to chronic diseases. Immunization dropped and polio resurfaced in the U.S., Australia, Africa and Russia. Research linking vaccines to chronic disease was dis- credited, but vaccine opponents remain active. Health educators are well positioned to mitigate damage caused by the anti-vaccine movement and address barriers to immunization efforts. Larsen D. The March of Dimes and polio: lessons in vaccine advocacy for health educators. Am J Health Educ. 2012;43(1):47-54. Submitted May 30, 2011. Accepted July 9, 2011. In 2008, The March of Dimes cel- prenatal health promotion programs, and of the virus that has been ranked second ebrated its 70th anniversary.
    [Show full text]
  • Drugs That Changed the World
    Drugs That Changed the World Drugs That Changed the World How Therapeutic Agents Shaped Our Lives Irwin W. Sherman CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2017 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed on acid-free paper Version Date: 20160922 International Standard Book Number-13: 978-1-4987-9649-1 (Hardback) This book contains information obtained from authentic and highly regarded sources. While all reasonable efforts have been made to publish reliable data and information, neither the author[s] nor the publisher can accept any legal respon- sibility or liability for any errors or omissions that may be made. The publishers wish to make clear that any views or opinions expressed in this book by individual editors, authors or contributors are personal to them and do not neces- sarily reflect the views/opinions of the publishers. The information or guidance contained in this book is intended for use by medical, scientific or health-care professionals and is provided strictly as a supplement to the medical or other professional’s own judgement, their knowledge of the patient’s medical history, relevant manufacturer’s instructions and the appropriate best practice guidelines. Because of the rapid advances in medical science, any information or advice on dosages, procedures or diagnoses should be independently verified. The reader is strongly urged to consult the relevant national drug formulary and the drug companies’ and device or material manufacturers’ printed instructions, and their websites, before administering or utilizing any of the drugs, devices or materials mentioned in this book.
    [Show full text]
  • Book of Essays by Young Scie
    Lasker Foundation and Diamonstein-Spielvogel Foundation Publish Book of Essays by Young Scientists Young scientists share personal stories of the legendary biomedical researchers and mentors who inspired their careers (New York City – November 10, 2020) – The Lasker Foundation and the Diamonstein- Spielvogel Foundation today announced the publication of “Inspiration: Young Scientists Reflect” edited by author, and advocate, Barbaralee Diamonstein-Spielvogel. The publication also honors the 75th Anniversary of the Albert and Mary Lasker Foundation, and the 25th Anniversary of the PEN America/Diamonstein-Spielvogel Art of the Essay Award. It includes a foreword, commissioned by the Diamonstein-Spielvogel Foundation, by author, journalist, and M.D., Rivka Galchen, who explores the history of the essay form and its early development by 16th century French humanist and philosopher Michel de Montaigne. It also contains a tribute to the PEN America/Diamonstein-Spielvogel Art of the Essay Award, by PEN America, the organization which stands at the intersection of literature and human rights to protect open expression in the United States and worldwide. The 11 essays in the booklet are the winning submissions to the 2020 Lasker Essay Contest, an annual global competition that engages young scientists and clinicians in discussion about the role of biomedical research in our society today. This year, students and young researchers were asked to describe how a notable scientist had inspired them – through the scientist’s personality, life experiences, and/or through their scientific contributions. The Lasker Foundation received over 300 submissions to the Contest. “These essays reflect the altruism of senior scientists as they guide younger men and women in the field and the power of mentorship in helping trainees define their endeavors in biomedical careers,” said Claire Pomeroy, president of the Lasker Foundation.
    [Show full text]